BOSTON — Roflumilast foam 0.3% was efficacious in improving itch and quality of life in seborrheic dermatitis patients, according to a poster presented at the AAD annual meeting.
“Seborrheic dermatitis is bad dandruff. It is a problem that affects many people around the world,” Zoe D. Draelos, MD, of Dermatology Consulting Services in High Point, North Carolina, and the study’s lead author, told Healio. “And we do not have any drugs in dermatology that are approved for the treatment of seborrheic dermatitis.”
This phase 2 , parallel-group, double-blind,